Search This Blog

Thursday, January 20, 2022

BioDelivery Sciences Sees 2021 Revenue at High End of Full Year Guidance

 Total 2021 Net Revenue expected in the range of $165 -$167 million, as compared to previous guidance of $162-$167 million

BELBUCA 2021 Net Sales expected to be in the range of $147 -$148 million, as compared to previous guidance of $144-$148 million

2021 EBITDA expected to be in the $40 - $45 million range as compared with previous guidance of <$40 million

https://finance.yahoo.com/news/biodelivery-sciences-expects-2021-revenue-130000629.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.